Press Release Distributed by ABNewswire.com To view the original version on ABNewswire visit: Coronary Stents Market ...

Table 2. Key trials investigating bioabsorbable polymer drug-eluting stents. Stent Key trials Patients (n) Primary end point Result Significance CoStar™ DES CoStar II 1700 Composite: death, non ...

However, the permanent polymers in first-generation sirolimus- and paclitaxel-eluting stent platforms used to control drug release may induce vascular hypersensitivity responses, which may ...

Various materials are used in the production of surgical stents, including metal, standard polymer, and biodegradable polymer, each offering unique benefits for different medical applications.

A new type of drug-eluting vascular stent, which uses materials found naturally in the human body rather than polymers (plastic), has been found to perform as well as commercially A "first-in-man ...

Due to advancements spurred by AI/ML, the impact of digital health technology will grow. Data from the Department for Promotion of Industry and Internal Trade show that FDI in the medicines and ...

Cardiovascular Diseases (CVDs), such as heart disease and stroke, and technological advancements in coronary stents are key factors driving market evenue growth VANCOUVER, BC, CANADA, March 6 ...